Radiology Doctors in Leawood, KS Accepting Medicare

6 Radiology doctors found. Showing 1 - 6

Dr. Jon Tony Madeira, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 5213 W 116th St, Leawood, KS 66211 Phone: 913-499-6835

John A Vadaparampil, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 11213 Brookwood Ave, Leawood, KS 66211 Phone: 813-494-5365    Fax: 913-588-7899

Dr. William Martin Reed, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 8944 Sagamore Rd, Leawood, KS 66206 Phone: 913-648-4695    Fax: 281-358-8531

Dr. Joseph Varriano, MD Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 4901 W 136th St, Leawood, KS 66224 Phone: 913-599-6777    Fax: 913-599-3955

Dennis M Wilcox, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3904 W 125th Terrace, Leawood, KS 66209 Phone: 216-255-5700    Fax: 216-255-5701

Bradford Scott Mccrary, MD PHD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 11216 Meadow Ln, Leawood, KS 66211 Phone: 803-239-6690

News Archive

Syngenta licenses chromatin gene stacking technology

Syngenta Biotechnology Inc. has announced that it has entered into a research and commercial license agreement for Chromatin's proprietary gene stacking technology.

Standard Register first quarter total revenues decline 4% to $157.6M

Standard Register today announced its financial results for the first quarter 2012. The Company reported revenue of $157.6 million and a net loss of $5.1 million, or $0.18 per share. The results compare to prior year revenue of $164.9 million and net income of $0.4 million, or $0.01 per diluted share.

Brain boosts processing of sexually arousing signals

Researchers at the University of Tampere and the Aalto University, Finland, have shown that the perception of nude bodies is boosted at an early stage of visual processing. The research was funded by the Academy of Finland.

Platinum and light together fight cancer

Researchers continue to search for cancer treatments that effectively destroy tumor cells while protecting surrounding healthy tissue and the body. One intriguing approach involves photoactivated drugs: an inactive precursor would be administered, then the diseased tissue could be irradiated to convert the drug into its cytotoxic form locally.

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

Read more Medical News

› Verified 1 days ago